Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review (Q37972025)

26 August 2017

Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review (English)

1 reference

26 August 2017

1 reference

1 reference

1

1 reference

26 August 2017

Yoon Kong Loke

2

1 reference

26 August 2017

1 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

35

1 reference

26 August 2017

2

1 reference

26 August 2017

127-139

1 reference

https://scigraph.springernature.com/pub.10.2165/11594900-000000000-00000

26 August 2017

0 references

cites work

Proton pump inhibitor and clopidogrel interaction: fact or fiction?

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Clopidogrel with or without omeprazole in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Differential effects of esomeprazole on the antiplatelet activity of clopidogrel in healthy individuals and patients after coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Effects of omeprazole on the antiplatelet activity of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Aspirin resistance and compliance with therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594900-000000000-00000

Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.

21 January 2018

1 reference

12 December 2020

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.

1 reference

12 December 2020

Paraoxonase-1 is a major determinant of clopidogrel efficacy

1 reference

12 December 2020

Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies

1 reference

12 December 2020

Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation

1 reference

12 December 2020

Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction

1 reference

12 December 2020

10.2165/11594900-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

22204719

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22204719